SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 142 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 11.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $403,000 | -47.0% | 184,925 | -9.0% | 0.00% | – |
Q2 2021 | $761,000 | +0.5% | 203,143 | -12.5% | 0.00% | – |
Q1 2021 | $757,000 | -38.6% | 232,189 | -35.7% | 0.00% | -100.0% |
Q4 2020 | $1,232,000 | +8.9% | 361,179 | +30.2% | 0.00% | 0.0% |
Q3 2020 | $1,131,000 | +34.6% | 277,502 | +11.6% | 0.00% | 0.0% |
Q2 2020 | $840,000 | +391.2% | 248,639 | +238.4% | 0.00% | – |
Q1 2020 | $171,000 | -49.4% | 73,475 | -20.9% | 0.00% | – |
Q4 2019 | $338,000 | -55.5% | 92,870 | +1.3% | 0.00% | -100.0% |
Q3 2019 | $760,000 | +13.4% | 91,677 | +17.9% | 0.00% | 0.0% |
Q2 2019 | $670,000 | -31.1% | 77,779 | -14.6% | 0.00% | 0.0% |
Q1 2019 | $973,000 | +36.8% | 91,127 | +12.2% | 0.00% | 0.0% |
Q4 2018 | $711,000 | -42.8% | 81,206 | +9.6% | 0.00% | 0.0% |
Q3 2018 | $1,244,000 | -42.5% | 74,073 | -28.3% | 0.00% | -50.0% |
Q2 2018 | $2,164,000 | +7.1% | 103,259 | -17.8% | 0.00% | 0.0% |
Q1 2018 | $2,021,000 | -4.0% | 125,636 | +13.1% | 0.00% | 0.0% |
Q4 2017 | $2,105,000 | +30.1% | 111,109 | -3.4% | 0.00% | 0.0% |
Q3 2017 | $1,618,000 | +130.5% | 114,991 | +22.1% | 0.00% | +100.0% |
Q2 2017 | $702,000 | -11.5% | 94,193 | -22.8% | 0.00% | 0.0% |
Q1 2017 | $793,000 | +72.0% | 121,965 | +17.3% | 0.00% | – |
Q4 2016 | $461,000 | +7.5% | 103,947 | +13.1% | 0.00% | – |
Q3 2016 | $429,000 | -68.7% | 91,911 | -55.9% | 0.00% | -100.0% |
Q2 2016 | $1,371,000 | +125.9% | 208,530 | +118.6% | 0.00% | +100.0% |
Q1 2016 | $607,000 | +38.0% | 95,395 | +30.9% | 0.00% | 0.0% |
Q4 2015 | $440,000 | -25.9% | 72,902 | -26.6% | 0.00% | 0.0% |
Q3 2015 | $594,000 | -53.2% | 99,264 | -46.5% | 0.00% | 0.0% |
Q2 2015 | $1,269,000 | +187.1% | 185,576 | +155.1% | 0.00% | – |
Q1 2015 | $442,000 | -64.2% | 72,755 | -59.2% | 0.00% | -100.0% |
Q4 2014 | $1,235,000 | +85.4% | 178,179 | +117.6% | 0.00% | 0.0% |
Q3 2014 | $666,000 | +20.9% | 81,900 | +20.5% | 0.00% | – |
Q2 2014 | $551,000 | -35.5% | 67,940 | -37.6% | 0.00% | -100.0% |
Q1 2014 | $854,000 | -34.0% | 108,942 | -25.5% | 0.00% | 0.0% |
Q4 2013 | $1,293,000 | +38.1% | 146,219 | +30.9% | 0.00% | 0.0% |
Q3 2013 | $936,000 | -37.7% | 111,692 | -44.5% | 0.00% | -50.0% |
Q2 2013 | $1,502,000 | +4.3% | 201,296 | +4.2% | 0.00% | +100.0% |
Q1 2013 | $1,440,000 | – | 193,102 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |